【Scinopharm】February 2026 Revenue Reaches NT$207 Million (YoY +26.3%)
Scinopharm (1789) announced its February 2026 monthly revenue of NT$207 million, a significant year-… · 2026-02-01
神隆 News Releases
【ScinoPharm】Announcement of Ex-Dividend Record Date and Cash Dividend Payment Date
ScinoPharm announced the board's resolution for cash dividend distribution. Shareholders will receiv… · 2026-05-27
[ScinoPharm] May 2026 Revenue of NT$175 Million (YoY -33.2%)
ScinoPharm Taiwan (TWSE: 1789), operating in the biotech and medical industry, announced its monthly… · 2026-05-01
[ScinoPharm] Announcement regarding the approval of the removal of non-compete restrictions for directors (including independent directors) and their representatives at the 116th Annual General Meeting
ScinoPharm announced that the 116th AGM approved the removal of non-compete restrictions for its dir… · 2026-05-27
[ScinoPharm] Announcement regarding the Board's approval to lift non-compete restrictions for managers
ScinoPharm has approved the lifting of non-compete restrictions for Chairman Luo Chih-hsien and Gene… · 2026-05-27
【ScinoPharm】Important Resolutions of the 115 Annual General Shareholders' Meeting
ScinoPharm held its Annual General Shareholders' Meeting on May 27, 115, approving a cash dividend o… · 2026-05-27
Shenlong: March 2026 Revenue Reaches 325 Million Yuan (Year-on-Year Increase of +3.4%)
Shenlong announced its March 2026 monthly revenue of 325 million yuan, marking a 3.4% increase compa… · 2026-03-01
[ScinoPharm] Invited to participate in an online investor conference hosted by Uni-President Securities
ScinoPharm has been invited to participate in an online investor conference hosted by Uni-President … · 2026-06-04
【Shenlon】April 2026 Monthly Revenue NT$255 Million (YoY +12.5%)
Shenlon's monthly revenue for April 2026 reached NT$255 million, a year-on-year increase of 12.5%. T… · 2026-04-01
【ScinoPharm】Announcement of the Board of Directors' approval of the Q1 2026 Consolidated Financial Report
ScinoPharm announced that its Board of Directors approved the consolidated financial report for the … · 2026-05-06
Announcement of Representative Director Change by Shinlong
Unified Enterprise (股) Company has announced a change in its representative director. Zheng Jingyuan… · 2026-04-30
ScinoPharm: Announcement of the Scheduled Board Meeting Date for the Company's Q1 2026 Consolidated Financial Report on May 6, 2026
ScinoPharm announced that its board of directors is scheduled to convene on May 6, 2026, to delibera… · 2026-04-28
Shenlong: March 2026 Revenue Reaches 325 Million Yuan (Year-on-Year Increase of +3.4%)
Shenlong announced its March 2026 monthly revenue of 325 million yuan, marking a 3.4% increase compa… · 2026-03-01
【Scinopharm】February 2026 Revenue Reaches NT$207 Million (YoY +26.3%)
Scinopharm (1789) announced its February 2026 monthly revenue of NT$207 million, a significant year-… · 2026-02-01
Announcement of Representative Director Change by Shinlong
Unified Enterprise (股) Company has announced a change in its representative director. Zheng Jingyuan… · 2026-04-30
ScinoPharm: Announcement of the Scheduled Board Meeting Date for the Company's Q1 2026 Consolidated Financial Report on May 6, 2026
ScinoPharm announced that its board of directors is scheduled to convene on May 6, 2026, to delibera… · 2026-04-28
【Shenlon】April 2026 Monthly Revenue NT$255 Million (YoY +12.5%)
Shenlon's monthly revenue for April 2026 reached NT$255 million, a year-on-year increase of 12.5%. T… · 2026-04-01
【ScinoPharm】Announcement of the Board of Directors' approval of the Q1 2026 Consolidated Financial Report
ScinoPharm announced that its Board of Directors approved the consolidated financial report for the … · 2026-05-06